Fig 4. ROC curves for predicting remission in biologic naïve patients (A) and non-naïve patients (B) to tocilizumab therapy.
ROC curve for sgp130 (gray line); ROC curve for sgp130, logsTNFR-II, logIP-10 and logIL-6 (black line).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.